Corpus Intelligence IC Memo — JOHNSON MEMORIAL HOSPITAL 2026-04-27 02:41 UTC
IC Memo — JOHNSON MEMORIAL HOSPITAL
Investment Committee Memorandum | MN | 17 beds | Grade C | EBITDA uplift $1.6M
🛡️ Public data only — no PHI permitted on this instance.
INVESTMENT COMMITTEE MEMORANDUM  ·  CCN 241314

JOHNSON MEMORIAL HOSPITAL

LOCATIONLAC QUI PARLE, MN·BEDS17·AS OFApril 27, 2026
C
INVESTABILITY
EBITDA BridgeData Room

1. Target Overview & Investment Thesis

JOHNSON MEMORIAL HOSPITAL is a 17-bed rural/critical access in LAC QUI PARLE, MN with $21.3M in net patient revenue and a -13.5% operating margin. The hospital serves a payer mix of 37.4% Medicare, 1.0% Medicaid, and 61.6% commercial.

Thesis: Turnaround. Our ML models identify $1.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -13.5% to -6.2% (+736bps).

Net Revenue HCRIS$21.3M
Current EBITDA COMPUTED$-2.9M
Operating Margin COMPUTED-13.5%
Occupancy HCRIS11.8%
Revenue / Bed COMPUTED$1.3M
Net-to-Gross HCRIS79.8%
Distress Probability ML61.6%

2. Market Context & Competitive Position

141
MN Hospitals
-3.6%
State Median Margin
89
Comparable Hospitals

MN has 141 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of -13.5% places it below the state median. Among 89 size-comparable peers (8-34 beds), the median margin is -2.6%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (8-34), prioritizing same-state peers. 89 hospitals in the comp set.

HospitalStateBedsRevenueMargin
JOHNSON MEMORIAL HOSPITAL (Target)MN17$21.3M-13.5%
CUYUNA REGIONAL MEDICAL CENTERMN25$180.8M-4.0%
MAYO CLINIC HEALTH SYSTEM - REMN27$149.3M1.8%
NEW ULM MEDICAL CENTERMN24$128.6M4.2%
LAKEWOOD HEALTH SYSTEMMN25$124.7M0.2%
GRAND ITASCA CLINIC AND HOSPITMN34$117.7M5.3%
AVERA MARSHALL REGIONAL MEDICAMN25$115.2M-17.0%
WELIA HEALTHMN25$106.7M1.1%
CCH-MONTICELLOMN25$97.7M9.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$448K+210bp18mo
Cost to Collect4.5%2.5%$427K+200bp12mo
Denial Rate Reduction12.0%6.5%$422K+198bp12mo
A/R Days Reduction5200.0%3800.0%$260K+122bp9mo
Clean Claim Rate88.0%96.0%$14K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$448K
Cost to Collect
$427K
Denial Rate Reduction
$422K
A/R Days Reduction
$260K
Clean Claim Rate
$14K
Total EBITDA Uplift$1.6M
Current EBITDA$-2.9M
+ RCM Uplift+$1.6M
Pro Forma EBITDA$-1.3M
Current Margin-13.5%
Pro Forma Margin-6.2%
WC Released (1x)$818K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-4.4M$-3.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-4.4M$-5.1M0.00x-100.0%
Bull Case9.0x11.0x$-4.0M$-1.4M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-4.0M$-2.7M0.00x-100.0%
Bear Case11.0x10.0x$-4.9M$-9.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-4.9M$-12.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 11.8%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 61.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 89 hospitals with 8-34 beds
  • Same-state prioritization (n=92)
  • Comp margins: P25=-12.1% / P50=-2.6% / P75=3.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 27, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.